APN, an adipocyte‐derived plasma protein that was discovered two decades ago, has gained attention as a potential therapeutic agent for osteoporosis and osteoporosis‐related bone fractures, primarily due to its roles in lipid metabolism and bone mineralization (Lenchik et al., 2003; Yokota et al., 2002). Here, ANPEP is linked to osteoporosis.